Sandhill Capital Partners »

Gain Therapeutics shares owned by Sandhill Capital Partners

Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by Sandhill Capital Partners from 13F filings

Historical chart of Sandhill Capital Partners investment in Gain Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Gain Therapeutics held by Sandhill Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gain Therapeutics by Sandhill Capital Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $27k 15k 1.77
2025-06-30 $28k 15k 1.80
2025-03-31 $29k 15k 1.91
2024-12-31 $33k 15k 2.16
2024-09-30 $27k 15k 1.78